Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

[1]  M. Gonda,et al.  Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus. , 1995, Laboratory animal science.

[2]  W. Leonard,et al.  Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome. , 1995, Journal of hematotherapy.

[3]  W. Leonard,et al.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.

[4]  E. Brooks,et al.  Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. , 1995, The Journal of clinical investigation.

[5]  J. Gribben,et al.  Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. , 1994, Science.

[6]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[7]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[8]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[9]  P. Felsburg,et al.  T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency. , 1994, Journal of immunology.

[10]  F. Rieux-Laucat,et al.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Puck,et al.  IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. , 1994, Genomics.

[12]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[13]  J M Ward,et al.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. , 1994, Journal of the National Cancer Institute.

[14]  H. Asao,et al.  Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency. , 1994, Journal of immunology.

[15]  W. Leonard,et al.  The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy. , 1994, Current opinion in immunology.

[16]  D. Raulet,et al.  Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes , 1994, The Journal of experimental medicine.

[17]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[18]  T. Waldmann,et al.  The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Horváth,et al.  Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL. , 1994, Journal of immunology.

[20]  A. Singer,et al.  Differential effects of zeta and eta transgenes on early alpha/beta T cell development , 1994, The Journal of experimental medicine.

[21]  W. Leonard,et al.  The Molecular Basis of X‐Linked Severe Combined Immunodeficiency: The Role of the Interleukin‐2 Receptor γ Chain as a Common γ Chain, γc , 1994, Immunological reviews.

[22]  R. Schwartz,et al.  A subset of CD4+ thymocytes selected by MHC class I molecules. , 1994, Science.

[23]  S. Nishikawa,et al.  Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. , 1994, Science.

[24]  A. Fischer,et al.  Interleukin‐2 (IL‐2) receptor γ chain mutations in X‐linked severe combined immunodeficiency disease result in the loss of high‐affinity IL‐2 receptor binding , 1994, European journal of immunology.

[25]  K. Rajewsky,et al.  Development and proliferation of lymphocytes in mice deficient for both interleukins‐2 and ‐4 , 1994, European journal of immunology.

[26]  松江 弘之.  Keratinocyte-derived IL-7 serves as a growth factor for dendritic epidermal T cells in mice , 1994 .

[27]  L. Lefrançois.  24 – Basic Aspects of Intraepithelial Lymphocyte Immunobiology , 1994 .

[28]  P. Ogra.  Handbook of mucosal immunology , 1994 .

[29]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[30]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[31]  N. Reich,et al.  Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. , 1993, Science.

[32]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[33]  W. Leonard,et al.  Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. Singer,et al.  T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. , 1993, Science.

[35]  Carolyn J. Brown,et al.  The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. , 1993, Human molecular genetics.

[36]  F. Finkelman,et al.  Inhibition of murine B and T lymphopoiesis in vivo by an anti- interleukin 7 monoclonal antibody , 1993, The Journal of experimental medicine.

[37]  W. Leonard,et al.  Characterization of the human interleukin-2 receptor gamma chain gene. , 1993, The Journal of biological chemistry.

[38]  J. Penninger,et al.  Requirement for tyrosine kinase p56lck for thymic development of transgenic gamma delta T cells , 1993, Science.

[39]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[40]  P. Snyder,et al.  Histologic characterization of the thymus in canine X-linked severe combined immunodeficiency. , 1993, Clinical immunology and immunopathology.

[41]  L. Herzenberg,et al.  Origin of murine B cell lineages. , 1993, Annual review of immunology.

[42]  R. Puri,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. , 1993, Science.

[43]  P. Cruz,et al.  Dendritic epidermal T cells: lessons from mice for humans. , 1993, The Journal of investigative dermatology.

[44]  J. Puck.  X-linked immunodeficiencies. , 1993, Advances in human genetics.

[45]  N. Tanaka,et al.  Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.

[46]  A. Lichtman,et al.  IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. , 1992, Journal of immunology.

[47]  M. Miyasaka,et al.  In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells. , 1992, International Immunology.

[48]  M. Conley,et al.  Molecular approaches to analysis of X-linked immunodeficiencies. , 1992, Annual review of immunology.

[49]  P. Felsburg,et al.  Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses. , 1992, Immunodeficiency reviews.

[50]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[51]  I. Horak,et al.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.

[52]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[53]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[54]  J. Allison,et al.  The immunobiology of T cells with invariant γδ antigen receptors , 1991 .

[55]  J. Allison,et al.  The immunobiology of T cells with invariant gamma delta antigen receptors. , 1991, Annual review of immunology.

[56]  E. Brooks,et al.  A novel X-linked combined immunodeficiency disease. , 1990, The Journal of clinical investigation.

[57]  J. Allison,et al.  Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors , 1990, Nature.

[58]  K. Wolff,et al.  Dendritic epidermal T cells: activation requirements and phenotypic characterization of proliferating cells. , 1989, Journal of Investigative Dermatology.

[59]  T. Honjo,et al.  Effects of the deregulated expression of human interleukin-2 in transgenic mice. , 1989, International immunology.

[60]  W. Leonard,et al.  The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. , 1987, Science.

[61]  C. Nezelof.  Pathology of the thymus in immunodeficiency states. , 1986, Current topics in pathology. Ergebnisse der Pathologie.

[62]  C. Griscelli,et al.  Severe combined immunodeficiency disease: a pathological analysis of 26 cases. , 1983, Clinical immunology and immunopathology.

[63]  E. Korn,et al.  Quantification of natural cytotoxicity by human lymphocyte subpopulations isolated by density: heterogeneity of the effector cells. , 1983, Journal of immunological methods.

[64]  J. Unkeless.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.